| 1 | Pharyngeal Neoplasms | 38.6% |
| 2 | Laryngeal neoplasm | 33.9% |
| 3 | Labyrinthitis | 32.7% |
| 4 | Nose Neoplasms | 28.8% |
| 5 | Hypopharyngeal Neoplasms | 28.1% |
| 6 | Hypopharyngeal Cancer | 28.1% |
| 7 | Otosclerosis | 27.8% |
| 8 | Tympanosclerosis | 27.8% |
| 9 | Nasopharyngeal Neoplasms | 26.3% |
| 10 | Paranasal Sinus Neoplasms | 23.6% |
| 11 | Tonsillar Neoplasms | 23% |
| 12 | Tympanic Membrane Perforation | 23% |
| 13 | Otomycosis | 22.4% |
| 14 | Congenital Microtia | 22.4% |
| 15 | Cochlear Diseases | 20.5% |
| 16 | Otitis Externa | 20.5% |
| 17 | Otitis Media | 20.5% |
| 18 | Vestibular Diseases | 20.5% |
| 19 | Endolymphatic Hydrops | 20.5% |
| 20 | Nasopharyngeal carcinoma | 19.9% |
| 21 | Maxillary Sinus Neoplasms | 19.3% |
| 22 | Acoustic Neuroma | 18.2% |
| 23 | Dysacusis | 18.2% |
| 24 | Laryngeal Diseases | 17.8% |
| 25 | Nose Diseases | 17.8% |
| 26 | Pharyngeal Diseases | 17.8% |
| 27 | Meniere Disease | 16.9% |
| 28 | Otitis Media with Effusion | 16.9% |
| 29 | Vestibulocochlear Nerve Diseases | 16.6% |
| 30 | Herpes Zoster Oticus | 15.5% |
| 31 | Parathyroid Neoplasms | 14.8% |
| 32 | Thyroid Neoplasm | 14.8% |
| 33 | Thyroid carcinoma | 14.8% |
| 34 | Mouth Neoplasms | 14.5% |
| 35 | Vestibular Neuronitis | 13.5% |
| 36 | Hyperacusis | 13.4% |
| 37 | Tinnitus | 13.4% |
| 38 | Phonophobia | 13.4% |
| 39 | Hearing Loss | 13.4% |
| 40 | Tracheal Neoplasms | 13.2% |
| 41 | Abdominal Neoplasms | 13% |
| 42 | Soft Tissue Neoplasms | 13% |
| 43 | Thoracic Neoplasms | 13% |
| 44 | Primary Ciliary Dyskinesia | 12.2% |
| 45 | Vertigo | 11.4% |
| 46 | Esophageal Neoplasms | 11.3% |
| 47 | Granuloma, Lethal Midline | 11.2% |
| 48 | Laryngeal Edema | 11.2% |
| 49 | Nose Deformities, Acquired | 11.2% |
| 50 | Mastoiditis | 11.1% |
| 51 | Petrositis | 11.1% |
| 52 | Deafness | 11% |
| 53 | Hearing Loss, Sudden | 11% |
| 54 | Deglutition Disorders | 11% |
| 55 | Hearing Loss, Bilateral | 11% |
| 56 | Hearing Loss, High-Frequency | 11% |
| 57 | Hearing Loss, Mixed Conductive-Sensorineural | 11% |
| 58 | Hearing Loss, Unilateral | 11% |
| 59 | Complete Hearing Loss | 11% |
| 60 | Deaf Mutism | 11% |
| 61 | Ear Diseases | 10.8% |
| 62 | Digestive System Neoplasms | 10.8% |
| 63 | Endocrine Gland Neoplasms | 10.8% |
| 64 | Eye Neoplasms | 10.8% |
| 65 | Nervous System Neoplasms | 10.8% |
| 66 | Bone neoplasms | 10.5% |
| 67 | Skin Neoplasms | 10.5% |
| 68 | Hematologic Neoplasms | 10.5% |
| 69 | Splenic Neoplasms | 10.3% |
| 70 | Nasopharyngitis | 10.1% |
| 71 | Thyroid Nodule | 9.6% |
| 72 | Laryngitis | 9.4% |
| 73 | Pharyngitis | 9.4% |
| 74 | Rhinitis | 9.4% |
| 75 | Vocal Cord Dysfunction | 9.4% |
| 76 | Laryngostenosis | 9.2% |
| 77 | Nasal Polyps | 9.2% |
| 78 | Ear Neoplasms | 9.2% |
| 79 | Peritoneal Neoplasms | 8.9% |
| 80 | Multiple Endocrine Neoplasia | 8.2% |
| 81 | Leukoplakia, Oral | 8.2% |
| 82 | Croup | 8.2% |
| 83 | Rhinitis, Vasomotor | 8.2% |
| 84 | Hamartoma | 8.1% |
| 85 | Neoplasms, Hormone-Dependent | 8.1% |
| 86 | Neoplasms, Multiple Primary | 8.1% |
| 87 | Paraneoplastic Syndromes | 8.1% |
| 88 | Precancerous Conditions | 8.1% |
| 89 | Neoplasms, Second Primary | 8.1% |
| 90 | Paraneoplastic Encephalomyelitis | 8.1% |
| 91 | Eyelid Neoplasms | 8% |
| 92 | Choanal Atresia | 8% |
| 93 | Voice Disorders | 8% |
| 94 | Voice Disturbance | 8% |
| 95 | Laryngocele | 8% |
| 96 | Mammary Neoplasms, Experimental | 8% |
| 97 | Epistaxis | 7.9% |
| 98 | Salivary Gland Neoplasms | 7.9% |
| 99 | Tongue Neoplasms | 7.9% |
| 100 | Pancreatic Neoplasm | 7.8% |
| 101 | Retroperitoneal Neoplasms | 7.7% |
| 102 | Acanthoma | 7.4% |
| 103 | Auditory Perceptual Disorders | 7.4% |
| 104 | Laryngomalacia | 6.9% |
| 105 | Granuloma, Laryngeal | 6.9% |
| 106 | Sinusitis | 6.9% |
| 107 | Vocal Cord Paralysis | 6.8% |
| 108 | Palatal Neoplasms | 6.8% |
| 109 | Laryngospasm | 6.8% |
| 110 | Tonsillitis | 6.8% |
| 111 | Cyst | 6.5% |
| 112 | Neoplastic Processes | 6.5% |
| 113 | Neoplastic Syndromes, Hereditary | 6.5% |
| 114 | Pregnancy Complications, Neoplastic | 6.5% |
| 115 | Neoplasms, Experimental | 6.4% |
| 116 | Central Nervous System Neoplasms | 6.2% |
| 117 | Vascular Neoplasms | 6.2% |
| 118 | Thymus Neoplasms | 6.2% |
| 119 | Genital Neoplasms, Female | 6.1% |
| 120 | Breast Neoplasms, Male | 6.1% |
| 121 | Triple Negative Breast Neoplasms | 6.1% |
| 122 | Lemierre Syndrome | 5.9% |
| 123 | Carcinoma, Lobular | 5.9% |
| 124 | Aphonia | 5.8% |
| 125 | Retropharyngeal Abscess | 5.8% |
| 126 | Dysphonia | 5.8% |
| 127 | Testicular Neoplasms | 5.6% |
| 128 | Rhinoscleroma | 5.4% |
| 129 | Neoplasms, Radiation-Induced | 5.3% |
| 130 | Adrenal Gland Neoplasms | 5.2% |
| 131 | Gastrointestinal Neoplasms | 5.2% |
| 132 | Genital Neoplasms, Male | 5.2% |
| 133 | Liver neoplasms | 5.2% |
| 134 | Uveal Neoplasms | 5.2% |
| 135 | Urologic Neoplasms | 5.1% |
| 136 | Sebaceous Gland Neoplasms | 5.1% |
| 137 | Spinal Neoplasms | 5.1% |
| 138 | Bone Marrow Neoplasms | 5.1% |
| 139 | Thymoma | 5.1% |
| 140 | Multiple Endocrine Neoplasia Type 1 | 5% |
| 141 | Meningioma | 5% |
| 142 | Parotid Neoplasms | 5% |
| 143 | Carcinoma, Pancreatic Ductal | 4.9% |
| 144 | Carcinoma, Ehrlich Tumor | 4.8% |
| 145 | Dermoid Cyst | 4.8% |
| 146 | Carcinoma, Lewis Lung | 4.8% |
| 147 | Carcinoma 256, Walker | 4.8% |
| 148 | Hay fever | 4.8% |
| 149 | Rhinitis, Allergic, Perennial | 4.8% |
| 150 | Peritonsillar Abscess | 4.7% |
| 151 | Liver Neoplasms, Experimental | 4.6% |
| 152 | Trophoblastic Neoplasms | 4.6% |
| 153 | Leukemia, Experimental | 4.5% |
| 154 | Hoarseness | 4.5% |
| 155 | Erythroplasia | 4.3% |
| 156 | Follicular cyst | 4.3% |
| 157 | leukemia | 4.3% |
| 158 | Mucocele | 4.3% |
| 159 | Neoplasms, Germ Cell and Embryonal | 4.3% |
| 160 | Neoplasms, Glandular and Epithelial | 4.3% |
| 161 | Pilonidal Cyst | 4.3% |
| 162 | Thyroglossal Cyst | 4.3% |
| 163 | Synovial Cyst | 4.3% |
| 164 | Germ Cell Cancer | 4.3% |
| 165 | Aberrant Crypt Foci | 4.3% |
| 166 | Paraneoplastic Cerebellar Degeneration | 4.3% |
| 167 | Tuberous Sclerosis | 4.3% |
| 168 | Neuroectodermal Tumors | 4.1% |
| 169 | Meningeal Neoplasms | 4.1% |
| 170 | Sarcoma, Experimental | 4% |
| 171 | Melanoma, Experimental | 4% |
| 172 | Leukemia, Radiation-Induced | 3.9% |
| 173 | Neoplasms, Neuroepithelial | 3.9% |
| 174 | Gliomatosis cerebri | 3.9% |
| 175 | Hepatocellular Adenoma | 3.8% |
| 176 | insulinoma | 3.8% |
| 177 | ovarian neoplasm | 3.8% |
| 178 | Nephroblastoma | 3.8% |
| 179 | Vipoma | 3.8% |
| 180 | Limbic Encephalitis | 3.7% |
| 181 | Pituitary Adenoma | 3.7% |
| 182 | Pituitary Neoplasms | 3.7% |
| 183 | Gastrinoma | 3.7% |
| 184 | Glucagonoma | 3.7% |
| 185 | Retinoblastoma | 3.7% |
| 186 | Kartagener Syndrome | 3.6% |
| 187 | Leukoplakia | 3.5% |
| 188 | Lymphocele | 3.5% |
| 189 | Pancreatic Cyst | 3.5% |
| 190 | Barrett Esophagus | 3.4% |
| 191 | Breast Cyst | 3.4% |
| 192 | Histiocytic Disorders, Malignant | 3.4% |
| 193 | Actinic keratosis | 3.4% |
| 194 | Lung Neoplasms | 3.4% |
| 195 | Mediastinal Cyst | 3.4% |
| 196 | Neoplasm Invasiveness | 3.4% |
| 197 | Neoplasm Metastasis | 3.4% |
| 198 | Neoplasm Recurrence, Local | 3.4% |
| 199 | Parovarian Cyst | 3.4% |
| 200 | Pericardial Cyst | 3.4% |
| 201 | Pleural Neoplasms | 3.4% |
| 202 | Thymic Cyst | 3.4% |
| 203 | Carcinogenesis | 3.4% |
| 204 | Myxoid cyst | 3.4% |
| 205 | Metastasis | 3.4% |
| 206 | Lambert-Eaton Myasthenic Syndrome | 3.4% |
| 207 | Carcinosarcoma | 3.4% |
| 208 | Hemangiosarcoma | 3.4% |
| 209 | Leukemia L1210 | 3.4% |
| 210 | Leukemia P388 | 3.4% |
| 211 | lymphangiosarcoma | 3.4% |
| 212 | Brain Neoplasms | 3.4% |
| 213 | Spinal Cord Neoplasms | 3.4% |
| 214 | melanoma | 3.3% |
| 215 | Uterine Neoplasms | 3.3% |
| 216 | Vaginal Neoplasms | 3.3% |
| 217 | Vulvar Neoplasms | 3.3% |
| 218 | Uterine Cancer | 3.3% |
| 219 | Fallopian Tube Neoplasms | 3.3% |
| 220 | Prolactinoma | 3.3% |
| 221 | Growth Hormone-Secreting Pituitary Adenoma | 3.3% |
| 222 | Leydig Cell Tumor | 3.2% |
| 223 | Lymphomatoid Granulomatosis | 3.1% |
| 224 | Choriocarcinoma | 3.1% |
| 225 | Optic Nerve Glioma | 3.1% |
| 226 | Sarcoma 180 | 3% |
| 227 | Opsoclonus-Myoclonus Syndrome | 3% |
| 228 | Meningeal Carcinomatosis | 3% |
| 229 | granulosa cell tumor | 2.9% |
| 230 | Carcinoma, Ovarian Epithelial | 2.9% |
| 231 | Central Nervous System Cysts | 2.9% |
| 232 | Medulloblastoma | 2.9% |
| 233 | Bile Duct Neoplasms | 2.9% |
| 234 | gallbladder neoplasm | 2.9% |
| 235 | Intestinal Neoplasms | 2.9% |
| 236 | Penile Neoplasms | 2.9% |
| 237 | Prostatic Neoplasms | 2.9% |
| 238 | Stomach Neoplasms | 2.9% |
| 239 | Composite Lymphoma | 2.9% |
| 240 | Lymphoma | 2.9% |
| 241 | Polycythemia Vera | 2.8% |
| 242 | Corpus Luteum Cyst | 2.8% |
| 243 | Ovarian Cysts | 2.8% |
| 244 | Adenomatous Polyposis Coli | 2.8% |
| 245 | Leukemia, Plasma Cell | 2.8% |
| 246 | Adenoma, Acidophil | 2.8% |
| 247 | Ganglioneuroma | 2.8% |
| 248 | Glioma | 2.8% |
| 249 | Malignant Glioma | 2.8% |
| 250 | Mesoblastic Nephroma | 2.7% |
| 251 | Myelitis, Transverse | 2.7% |
| 252 | Basal cell carcinoma | 2.7% |
| 253 | Carcinoma, Papillary | 2.7% |
| 254 | Squamous cell carcinoma | 2.7% |
| 255 | Chondrosarcoma | 2.7% |
| 256 | Craniopharyngioma | 2.7% |
| 257 | Cystadenoma | 2.7% |
| 258 | leiomyosarcoma | 2.7% |
| 259 | liposarcoma | 2.7% |
| 260 | Mesothelioma | 2.7% |
| 261 | synovial sarcoma | 2.7% |
| 262 | Neuroectodermal Tumor, Melanotic | 2.7% |
| 263 | Angiomyolipoma | 2.7% |
| 264 | Clear Cell Sarcoma of Soft Tissue | 2.7% |
| 265 | Alveolar Soft Part Sarcoma | 2.7% |
| 266 | Neuroendocrine Tumors | 2.7% |
| 267 | Sarcoma, Myeloid | 2.7% |
| 268 | Carcinoma, Basal Cell | 2.7% |
| 269 | Basal Cell Nevus Syndrome | 2.6% |
| 270 | Adenoma | 2.6% |
| 271 | Ameloblastoma | 2.6% |
| 272 | Angiokeratoma | 2.6% |
| 273 | Carcinoma | 2.6% |
| 274 | Chordoma | 2.6% |
| 275 | Hemangioma | 2.6% |
| 276 | hemangiopericytoma | 2.6% |
| 277 | Lymphangioma | 2.6% |
| 278 | Mesenchymoma | 2.6% |
| 279 | Nevus | 2.6% |
| 280 | Teratoma | 2.6% |
| 281 | Hepatoblastoma | 2.6% |
| 282 | Mixed Tumor, Mullerian | 2.6% |
| 283 | Germinoma | 2.6% |
| 284 | Teratocarcinoma | 2.6% |
| 285 | Angiofibroma | 2.6% |
| 286 | Sarcoma | 2.6% |
| 287 | Epithelioma | 2.6% |
| 288 | Bronchial Neoplasms | 2.5% |
| 289 | Multiple Pulmonary Nodules | 2.5% |
| 290 | Bladder Neoplasm | 2.5% |
| 291 | Kidney Neoplasm | 2.5% |
| 292 | Ureteral Neoplasms | 2.5% |
| 293 | Urethral Neoplasms | 2.5% |
| 294 | Supratentorial Neoplasms | 2.5% |
| 295 | Carcinoid Tumor | 2.5% |
| 296 | Endometrial Neoplasms | 2.5% |
| 297 | Neurilemmoma | 2.5% |
| 298 | Hutchinson's Melanotic Freckle | 2.5% |
| 299 | Melanoma, Amelanotic | 2.5% |
| 300 | Adrenocortical carcinoma | 2.5% |
| 301 | Choledochal Cyst | 2.5% |
| 302 | Peutz-Jeghers Syndrome | 2.4% |
| 303 | Cystadenocarcinoma | 2.3% |
| 304 | Fibrosarcoma | 2.3% |
| 305 | Osteosarcoma | 2.3% |
| 306 | Mucoepidermoid Carcinoma | 2.3% |
| 307 | Astrocytoma | 2.2% |
| 308 | Ependymoma | 2.2% |
| 309 | oligodendroglioma | 2.2% |
| 310 | Ganglioglioma | 2.2% |
| 311 | gliosarcoma | 2.2% |
| 312 | Anaplastic astrocytoma | 2.2% |
| 313 | Anaplastic Oligodendroglioma | 2.2% |
| 314 | Renal Cell Carcinoma | 2.2% |
| 315 | Papillary Renal Cell Carcinoma | 2.2% |
| 316 | Adenofibroma | 2.2% |
| 317 | Fibroadenoma | 2.2% |
| 318 | Malignant Fibrous Histiocytoma | 2.2% |
| 319 | Pleural Effusion, Malignant | 2.2% |
| 320 | Prostatic Neoplasms, Castration-Resistant | 2.1% |
| 321 | Endometrial Stromal Sarcoma | 2.1% |
| 322 | Nelson Syndrome | 2.1% |
| 323 | Brain Stem Neoplasms | 2.1% |
| 324 | Malignant Carcinoid Syndrome | 2.1% |
| 325 | Pancreatic Pseudocyst | 2% |
| 326 | Plasmacytoma | 2% |
| 327 | Malignant histiocytosis | 2% |
| 328 | Lymphatic Metastasis | 2% |
| 329 | Neoplasms, Unknown Primary | 2% |
| 330 | Leukemic Infiltration | 2% |
| 331 | Histiocytic sarcoma | 2% |
| 332 | Neoplasm Micrometastasis | 2% |
| 333 | Bowen's Disease | 2% |
| 334 | Paraganglioma | 2% |
| 335 | Rhabdomyosarcoma | 2% |
| 336 | Giant Cell Tumor of Bone | 2% |
| 337 | Hydatidiform Mole | 1.9% |
| 338 | Glioblastoma | 1.9% |
| 339 | Neuroblastoma | 1.9% |
| 340 | Glioblastoma Multiforme | 1.9% |
| 341 | Carcinoma, Endometrioid | 1.9% |
| 342 | Lymphangioleiomyomatosis | 1.9% |
| 343 | Denys-Drash Syndrome | 1.9% |
| 344 | Cecal Neoplasms | 1.9% |
| 345 | Duodenal Neoplasms | 1.9% |
| 346 | Choroid Plexus Papilloma | 1.9% |
| 347 | Dermatofibrosarcoma | 1.8% |
| 348 | Dermatofibrosarcoma Protuberans | 1.8% |
| 349 | Ganglioneuroblastoma | 1.8% |
| 350 | Cerebellar Neoplasms | 1.8% |
| 351 | Neurofibrosarcoma | 1.7% |
| 352 | Adenocarcinoma | 1.7% |
| 353 | Carcinoma in Situ | 1.7% |
| 354 | Carcinoma, Transitional Cell | 1.7% |
| 355 | Phyllodes Tumor | 1.7% |
| 356 | Dysgerminoma | 1.7% |
| 357 | Hemangioendothelioma | 1.7% |
| 358 | Lipoma | 1.7% |
| 359 | Myoma | 1.7% |
| 360 | Myxoma | 1.7% |
| 361 | Neuroma | 1.7% |
| 362 | Papilloma | 1.7% |
| 363 | Pseudomyxoma Peritonei | 1.7% |
| 364 | Seminoma | 1.7% |
| 365 | Papillomatosis | 1.7% |
| 366 | Angiolipoma | 1.7% |
| 367 | Myelolipoma | 1.7% |
| 368 | Neoplasms, Bone Tissue | 1.7% |
| 369 | Neoplasms, Fibrous Tissue | 1.7% |
| 370 | Smooth Muscle Tumor | 1.7% |
| 371 | Adenomatosis, Pulmonary | 1.7% |
| 372 | Adenomatous Polyps | 1.7% |
| 373 | Carcinoma, Large Cell | 1.7% |
| 374 | Carcinoma, Small Cell | 1.7% |
| 375 | Desmoplastic Small Round Cell Tumor | 1.7% |
| 376 | Chondroma | 1.7% |
| 377 | Enchondroma | 1.7% |
| 378 | Hodgkin Disease | 1.7% |
| 379 | Lymphoma, Non-Hodgkin | 1.7% |
| 380 | Polycystic Ovary Syndrome | 1.7% |
| 381 | Pheochromocytoma | 1.7% |
| 382 | Alveolar rhabdomyosarcoma | 1.7% |
| 383 | Colorectal Neoplasms | 1.6% |
| 384 | Carcinoid Heart Disease | 1.6% |
| 385 | Xeroderma Pigmentosum | 1.5% |
| 386 | Appendiceal Neoplasms | 1.5% |
| 387 | Colonic Neoplasms | 1.5% |
| 388 | Rectal Neoplasms | 1.5% |
| 389 | Primary amyloidosis | 1.4% |
| 390 | Leukemia, Myelomonocytic, Chronic | 1.3% |
| 391 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.3% |
| 392 | Adenoid Cystic Carcinoma | 1.3% |
| 393 | fibroma | 1.3% |
| 394 | Fibromatosis | 1.3% |
| 395 | Osteoblastoma | 1.3% |
| 396 | Osteoma | 1.3% |
| 397 | Rhabdomyoma | 1.3% |
| 398 | Chondromatosis | 1.3% |
| 399 | Adenocarcinoma, Clear Cell | 1.3% |
| 400 | Cholangiocarcinoma | 1.3% |
| 401 | Cervical Intraepithelial Neoplasia | 1.3% |
| 402 | Hemangioblastoma | 1.3% |
| 403 | Lymphoma, Extranodal NK-T-Cell | 1.3% |
| 404 | Anus Neoplasms | 1.2% |
| 405 | Sigmoid Neoplasms | 1.2% |
| 406 | Mastocytosis | 1.1% |
| 407 | Sturge-Weber Syndrome | 1.1% |
| 408 | Cell Transformation, Viral | 1.1% |
| 409 | Gastrointestinal Stromal Tumors | 1.1% |
| 410 | Hemangioma, Cavernous | 1.1% |
| 411 | Waldenstrom Macroglobulinemia | 1.1% |
| 412 | Multiple Myeloma | 1.1% |
| 413 | Leukemia, T-Cell | 1.1% |
| 414 | Leukemia, B-Cell | 1.1% |
| 415 | neurofibroma | 1.1% |
| 416 | Lymphoma, Follicular | 1.1% |
| 417 | T-Cell Lymphoma | 1.1% |
| 418 | Mantle cell lymphoma | 1.1% |
| 419 | Fibromatosis, Aggressive | 1.1% |
| 420 | Fibromatosis, Abdominal | 1.1% |
| 421 | Klatskin Tumor | 1.1% |
| 422 | Mastocytoma | 1% |
| 423 | Mastocytosis, Systemic | 1% |
| 424 | Zollinger-Ellison syndrome | 1% |
| 425 | Leukemia, Myeloid, Chronic-Phase | 1% |
| 426 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 427 | Leukemia, Large Granular Lymphocytic | 0.8% |
| 428 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 429 | Lymphoma, T-Cell, Cutaneous | 0.8% |
| 430 | Lymphoma, AIDS-Related | 0.8% |
| 431 | Enteropathy-Associated T-Cell Lymphoma | 0.8% |
| 432 | Primary Effusion Lymphoma | 0.8% |
| 433 | Dupuytren Contracture | 0.7% |
| 434 | Urticaria Pigmentosa | 0.7% |
| 435 | Mycosis Fungoides | 0.7% |
| 436 | Lymphomatoid Papulosis | 0.7% |
| 437 | Plasmablastic lymphoma | 0.7% |
| 438 | Burkitt Lymphoma | 0.6% |
| 439 | Sezary Syndrome | 0.5% |
| 440 | Radicular Cyst | 0.5% |